JP2007511582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511582A5 JP2007511582A5 JP2006540446A JP2006540446A JP2007511582A5 JP 2007511582 A5 JP2007511582 A5 JP 2007511582A5 JP 2006540446 A JP2006540446 A JP 2006540446A JP 2006540446 A JP2006540446 A JP 2006540446A JP 2007511582 A5 JP2007511582 A5 JP 2007511582A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- alkyl
- composition according
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 150000002148 esters Chemical class 0.000 claims 5
- 208000017169 kidney disease Diseases 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- -1 dioxolanylmethyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical group C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 claims 1
- JBRHCMAUNJIELM-UHFFFAOYSA-N 2-(1-benzazepin-1-yl)-2-oxoacetic acid Chemical compound OC(=O)C(=O)N1C=CC=CC2=CC=CC=C12 JBRHCMAUNJIELM-UHFFFAOYSA-N 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 201000001474 proteinuria Diseases 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104264.1 | 2003-11-18 | ||
| EP03104264 | 2003-11-18 | ||
| PCT/EP2004/052963 WO2005049035A1 (en) | 2003-11-18 | 2004-11-15 | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007511582A JP2007511582A (ja) | 2007-05-10 |
| JP2007511582A5 true JP2007511582A5 (cg-RX-API-DMAC10.html) | 2007-11-22 |
| JP4824573B2 JP4824573B2 (ja) | 2011-11-30 |
Family
ID=34610099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006540446A Expired - Fee Related JP4824573B2 (ja) | 2003-11-18 | 2004-11-15 | 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物 |
Country Status (15)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001036610A1 (en) * | 1999-11-19 | 2001-05-25 | Solvay Pharmaceuticals B.V. | Human enzymes of the metalloprotease family |
| PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| US20060159748A1 (en) * | 2004-12-23 | 2006-07-20 | Rajesh Jain | Oral immediate release formulation of a poorly water-soluble active substance |
| US11844803B2 (en) * | 2017-12-11 | 2023-12-19 | Aetas Pharma Co., Ltd. | Renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative |
| PL424453A1 (pl) * | 2018-01-31 | 2019-08-12 | Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością | Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) |
| ES2899200T3 (es) * | 2018-06-22 | 2022-03-10 | Synact Pharma Aps | Tratamiento de proteinuria |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0254032A3 (en) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| DE19510566A1 (de) | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19638020A1 (de) * | 1996-09-18 | 1998-03-19 | Solvay Pharm Gmbh | Die gastrointestinale Durchblutung fördernde Arzneimittel |
| DE19906310A1 (de) * | 1999-02-16 | 2000-08-17 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von Bluthochdruck |
| DE19932555A1 (de) * | 1999-07-13 | 2001-01-18 | Solvay Pharm Gmbh | Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen |
| SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| IL162645A0 (en) * | 2002-01-16 | 2005-11-20 | Solvay Pharm Bv | solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds |
| TW200306799A (en) * | 2002-05-17 | 2003-12-01 | Novartis Ag | Combination of organic compounds |
-
2004
- 2004-11-15 AR ARP040104208A patent/AR046454A1/es not_active Application Discontinuation
- 2004-11-15 CN CNB2004800330307A patent/CN100566719C/zh not_active Expired - Fee Related
- 2004-11-15 PL PL04818828T patent/PL1687006T3/pl unknown
- 2004-11-15 BR BRPI0416706-6A patent/BRPI0416706A/pt not_active IP Right Cessation
- 2004-11-15 JP JP2006540446A patent/JP4824573B2/ja not_active Expired - Fee Related
- 2004-11-15 AU AU2004290925A patent/AU2004290925B2/en not_active Ceased
- 2004-11-15 ES ES04818828T patent/ES2297536T3/es not_active Expired - Lifetime
- 2004-11-15 MX MXPA06005547A patent/MXPA06005547A/es active IP Right Grant
- 2004-11-15 DE DE602004010172T patent/DE602004010172T2/de not_active Expired - Lifetime
- 2004-11-15 TW TW093134862A patent/TWI344366B/zh not_active IP Right Cessation
- 2004-11-15 AT AT04818828T patent/ATE378053T1/de not_active IP Right Cessation
- 2004-11-15 EP EP04818828A patent/EP1687006B1/en not_active Expired - Lifetime
- 2004-11-15 CA CA002545802A patent/CA2545802A1/en not_active Abandoned
- 2004-11-15 WO PCT/EP2004/052963 patent/WO2005049035A1/en not_active Ceased
- 2004-11-16 US US10/988,847 patent/US7273860B2/en not_active Expired - Fee Related